发明名称 Isolation of urokinase
摘要 Urokinase is purified by elution from a precipitate with a dilute aqueous solution of 6,9-diamino-2-ethoxyacridine. Alternatively, the urokinase and impurities may be absorbed on calcium phosphate gel in the presence of 6,9-diamino - 2 - ethoxyacridine and the urokinase alone removed by extracting with a phosphate buffer. In a further alternative a urokinase-containing precipitate is washed with acidulated water at pH 3.2-5.5 and the urokinase then extracted with acidulated water at pH 1.5-3. Further purification is by adsorption on carboxymethyl cellulose followed by elution, dialysing and salting out which produces urokinase in crystalline form.ALSO:Purified crystalline urokinase free from pyrogens, thromboplastic substances and potentially antigenic impurities (see Division C3) may be used to treat intravascular clots in humans without producing allergic reactions.
申请公布号 GB1068817(A) 申请公布日期 1967.05.17
申请号 GB19650042311 申请日期 1965.10.05
申请人 STERLING DRUG INC. 发明人
分类号 A61K35/22;C12N9/72 主分类号 A61K35/22
代理机构 代理人
主权项
地址